Champions Oncology, Inc.
NASDAQ:CSBR
4.475 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 50.155 | 53.87 | 49.109 | 41.04 | 32.123 | 27.067 | 20.241 | 15.411 | 11.182 | 8.863 | 11.55 | 8.265 | 7.149 | 6.882 | 4.893 | 3.71 | 1.4 | 0 | 0 | 1.797 | 1.999 | 2.006 | 2.128 | 2.21 | 2.177 | 2.2 | 2.33 | 2.16 | 2.14 |
| Cost of Revenue
| 29.401 | 29.532 | 23.632 | 21.474 | 16.882 | 14.265 | 10.553 | 9.703 | 8.686 | 7.633 | 6.263 | 5.318 | 4.899 | 3.142 | 1.979 | 1.98 | 0 | 0 | 0 | 0.554 | 0.601 | 0.502 | 0.595 | 0.64 | 1.787 | 1.17 | 1.21 | 1.04 | 1.06 |
| Gross Profit
| 20.754 | 24.338 | 25.477 | 19.566 | 15.241 | 12.802 | 9.688 | 5.708 | 2.496 | 1.23 | 5.287 | 2.947 | 2.25 | 3.74 | 2.914 | 1.73 | 1.4 | 0 | 0 | 1.243 | 1.398 | 1.505 | 1.533 | 1.571 | 0.389 | 1.03 | 1.12 | 1.12 | 1.08 |
| Gross Profit Ratio
| 0.414 | 0.452 | 0.519 | 0.477 | 0.474 | 0.473 | 0.479 | 0.37 | 0.223 | 0.139 | 0.458 | 0.357 | 0.315 | 0.543 | 0.596 | 0.466 | 1 | 0 | 0 | 0.692 | 0.699 | 0.75 | 0.72 | 0.711 | 0.179 | 0.468 | 0.481 | 0.519 | 0.505 |
| Reseach & Development Expenses
| 9.544 | 11.545 | 9.374 | 7.196 | 5.853 | 4.798 | 4.401 | 4.293 | 4.194 | 4.845 | 2.265 | 1.918 | 2.937 | 2.951 | 2.695 | 1.721 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 11.067 | 10.24 | 9.117 | 6.512 | 6.614 | 4.678 | 4.071 | 4.963 | 5.173 | 5.34 | 6.127 | 4.709 | 5.45 | 4.611 | 0 | 0 | 0 | 0 | 0 | 0 | 0.277 | 0 | 0 | 0 | 0 | 0.95 | 1 | 0.99 | 0.96 |
| Selling & Marketing Expenses
| 7.064 | 7.002 | 6.379 | 5.52 | 4.242 | 3.056 | 2.57 | 3.261 | 3.445 | 4.283 | 3.155 | 2.668 | 2.928 | 1.413 | 0 | 0 | 0 | 0 | 0 | 0 | 1.18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 18.131 | 17.242 | 15.496 | 12.032 | 10.856 | 7.734 | 6.641 | 8.224 | 8.618 | 9.623 | 9.282 | 7.377 | 8.378 | 6.024 | 3.147 | 2.055 | 1.194 | 0.17 | 0.144 | 1.442 | 1.457 | 1.602 | 1.6 | 1.688 | 0.322 | 0.95 | 1 | 0.99 | 0.96 |
| Other Expenses
| 0.048 | -0.011 | -0.024 | 0.071 | -0.042 | -0.039 | -0.088 | -0.056 | -0.038 | 0.225 | -1.129 | -0.099 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.048 | 0.048 | 0.048 | 0.08 | 0.352 | 0.052 | 0.06 | 0.05 | 0.06 | 0.07 |
| Operating Expenses
| 27.675 | 28.787 | 24.87 | 19.228 | 16.709 | 12.532 | 11.042 | 12.517 | 12.812 | 14.468 | 11.547 | 9.295 | 11.315 | 8.975 | 5.842 | 3.776 | 1.393 | 0.17 | 0.144 | 1.49 | 1.505 | 1.651 | 1.68 | 2.04 | 0.374 | 1.01 | 1.05 | 1.05 | 1.03 |
| Operating Income
| -6.921 | -4.449 | 0.607 | 0.338 | -1.468 | 0.27 | -1.354 | -6.809 | -10.316 | -13.238 | -6.26 | -6.347 | -9.065 | -5.235 | -2.928 | -2.33 | 0.007 | -0.17 | -0.144 | -0.247 | -0.108 | -0.146 | -0.147 | -0.469 | 0.015 | 0.02 | 0.07 | 0.07 | 0.05 |
| Operating Income Ratio
| -0.138 | -0.083 | 0.012 | 0.008 | -0.046 | 0.01 | -0.067 | -0.442 | -0.923 | -1.494 | -0.542 | -0.768 | -1.268 | -0.761 | -0.598 | -0.628 | 0.005 | 0 | 0 | -0.137 | -0.054 | -0.073 | -0.069 | -0.212 | 0.007 | 0.009 | 0.03 | 0.032 | 0.023 |
| Total Other Income Expenses Net
| -0.387 | -0.818 | -0.024 | 0.071 | -0.377 | -0.039 | -0.088 | -0.056 | -0.038 | 0.225 | -1.129 | -0.099 | 0.402 | 1.444 | 0.005 | -0.284 | 0.029 | 0 | 0 | 0.01 | 0 | 0.011 | -0.038 | -0.284 | 0.018 | 0 | 0.29 | 0 | 0 |
| Income Before Tax
| -7.308 | -5.267 | 0.583 | 0.409 | -1.845 | 0.231 | -1.442 | -6.865 | -10.354 | -13.013 | -7.389 | -6.446 | -8.663 | -3.791 | -2.923 | -2.242 | 0.036 | -0.17 | -0.144 | -0.247 | -0.108 | -0.146 | -0.147 | -0.469 | 0.033 | 0.02 | 0.36 | 0.07 | 0.05 |
| Income Before Tax Ratio
| -0.146 | -0.098 | 0.012 | 0.01 | -0.057 | 0.009 | -0.071 | -0.445 | -0.926 | -1.468 | -0.64 | -0.78 | -1.212 | -0.551 | -0.597 | -0.604 | 0.025 | 0 | 0 | -0.137 | -0.054 | -0.073 | -0.069 | -0.212 | 0.015 | 0.009 | 0.155 | 0.032 | 0.023 |
| Income Tax Expense
| -0.032 | 0.068 | 0.035 | 0.075 | 0.13 | 0.103 | 0.063 | 0.019 | 0.092 | 0.127 | 0.017 | 0.01 | -0.002 | 0.011 | 0 | 0.196 | 0 | 0 | 0.16 | 0 | 0 | 0 | 0 | 0.208 | -0.036 | 0 | 0.01 | -0.22 | 0 |
| Net Income
| -7.276 | -5.335 | 0.548 | 0.362 | -1.975 | 0.128 | -1.505 | -6.884 | -10.446 | -13.14 | -7.406 | -6.446 | -8.661 | -3.802 | -2.923 | -2.242 | 0.036 | -0.17 | -0.304 | -0.247 | -0.108 | -0.146 | -0.147 | -0.677 | 0.052 | 0.02 | 0.36 | 0.29 | 0.05 |
| Net Income Ratio
| -0.145 | -0.099 | 0.011 | 0.009 | -0.061 | 0.005 | -0.074 | -0.447 | -0.934 | -1.483 | -0.641 | -0.78 | -1.211 | -0.552 | -0.597 | -0.604 | 0.025 | 0 | 0 | -0.137 | -0.054 | -0.073 | -0.069 | -0.306 | 0.024 | 0.009 | 0.155 | 0.134 | 0.023 |
| EPS
| -0.54 | -0.39 | 0.042 | 0.028 | -0.17 | 0.011 | -0.14 | -0.64 | -1.2 | -1.51 | -1.33 | -2.17 | -2.22 | -1.35 | -1.04 | -0.81 | -0.12 | -0.1 | -0.22 | -0.22 | -0.15 | -0.21 | -0.21 | -0.95 | 0.006 | 0.028 | 0.49 | 0.39 | 0.075 |
| EPS Diluted
| -0.54 | -0.39 | 0.039 | 0.025 | -0.17 | 0.009 | -0.14 | -0.63 | -1.2 | -1.51 | -1.32 | -2.17 | -2.22 | -1.35 | -1.04 | -0.81 | -0.12 | -0.1 | -0.22 | -0.22 | -0.15 | -0.21 | -0.21 | -0.95 | 0.006 | 0.028 | 0.49 | 0.39 | 0.075 |
| EBITDA
| -5.054 | -1.396 | 2.234 | 1.522 | -0.308 | 0.876 | -0.994 | -6.641 | -10.16 | -13.024 | -6.047 | -6.145 | -9.362 | -6.637 | -2.896 | -1.758 | 0.177 | -0.159 | -0.144 | -0.208 | -0.059 | -0.108 | -0.061 | -0.128 | 0.048 | 0.08 | 0.43 | 0.12 | 0.12 |
| EBITDA Ratio
| -0.101 | -0.026 | 0.045 | 0.037 | -0.01 | 0.032 | -0.049 | -0.431 | -0.909 | -1.469 | -0.524 | -0.743 | -1.31 | -0.964 | -0.592 | -0.474 | 0.126 | 0 | 0 | -0.116 | -0.03 | -0.054 | -0.029 | -0.058 | 0.022 | 0.036 | 0.185 | 0.056 | 0.056 |